Siemens Aktiengesellschaft (SMAWF)
NEUTRALFundamental
62
Price
$334.00
Market Cap
$249.04B
Part 1 · What the company is worth
Overview
Siemens sells the automation equipment, software and electrical infrastructure that factories, buildings and rail systems run on, plus it majority-owns Siemens Healthineers, a separately listed medical-imaging and diagnostics company. Its factory-automation and infrastructure businesses sell to industrial and construction customers worldwide; its rail unit builds trains and signaling systems for transit operators. The common thread across the divisions is selling equipment and software that customers depend on for years, not months.
How it makes money
Revenue comes mostly from selling hardware and software for factory automation, building systems and rail equipment, often bundled with long-term service and maintenance contracts that generate recurring income after the initial sale. Siemens Healthineers, consolidated into group results even though it trades as its own stock, adds revenue from selling and servicing imaging machines and diagnostic equipment to hospitals, a business with its own multi-year sales and service cycle.
Revenue by segment
Majority-owned, separately listed medical technology business selling imaging and diagnostic equipment to hospitals; Siemens' largest segment.
Electrical products, building automation and grid technology sold to construction and utility customers.
Factory automation hardware and industrial software used to design and run manufacturing plants; the segment that declined in fiscal 2025.
Trains, rail infrastructure and signaling systems sold to public transit operators and railways.
Competitive moat
Switching costs · NarrowOnce a factory or hospital is built around Siemens automation systems, imaging equipment or signaling technology, replacing it means retraining staff and requalifying processes, which discourages switching for years. The advantage is narrow rather than wide because each division faces capable global rivals — Schneider Electric and Rockwell in automation, GE Healthcare and Philips in imaging, Alstom in rail — that win contracts on price and features.
What drives demand
CyclicalIndustrial automation spending tracks factory investment cycles, which slow when manufacturers cut capital budgets in a downturn, and rail and infrastructure orders depend on large, lumpy public and private capital projects. Healthineers is the exception: hospital spending on imaging and diagnostics is comparatively steady, which softens the swings from the more industrial divisions.
The case for
Buyers point to steady growth at Smart Infrastructure and Mobility, resilient demand for Healthineers' hospital equipment, and long-lived customer relationships across the automation business as reasons the group can keep compounding revenue even as one division has a soft year.
The case against
Sellers worry that Digital Industries' decline signals weaker manufacturing capital spending that could spread to other divisions in a broader downturn, and that running four largely unrelated global businesses, one of them a separately listed subsidiary, makes the group harder to value and manage than a set of focused competitors.
Written by the editors, published on August 18, 2026
Direct competitors
Who this company fights with for the same customers
No editorial profile for this company yet
No competitor list for this company yet.
Balance Sheet & Liquidity
Revenue
$81.12B
Trailing 12 months (through 6/30/2026)
Net Income
$7.95B
Trailing 12 months (through 6/30/2026)
Free Cash Flow
$6.50B
Total Equity
$72.70B
Total Liabilities
$49.92B
Current Ratio
1.44
Interest Coverage
-
Debt/EBITDA
3.99
Earnings Per Share
Revenue & Net Income
Free Cash Flow
Income Breakdown
Historical statement
Margins over time
Debt over time
How heavy the debt is
Growth grid
Growth — Revenue
Fair Value Estimation
Fair Value
$257.48
Current Price
$334.00
Margin of Safety
-29.7%
Fair Value Range
$167.36 - $347.59
Estimation Methods
Valuation Metrics
P/E Ratio
27.93
ROE
12.5%
P/B Ratio
3.43
P/FCF
38.29
Gross Margin
39.4%
ROIC
7.8%
Profitability Radar
Value Creation (Economic Moat)
ROIC
7.8%
WACC
9.7%
ROIC − WACC
-1.9 pp
ROIC is below the cost of capital — the company is destroying value for every dollar invested.
Fundamental Analysis Criteria
Passed (13)
- Price CAGR 10.34%
- ROIC 7.8%
- Gross Margin 39.4%
- Debt/Equity ratio
- Positive Free Cash Flow
- Current Ratio
- Debt/EBITDA
- ROE 12.2%
- Revenue Growth 5Y 7.4%
- Analyst Consensus 74% Buy
- PEG Ratio 1.37
- Earnings Quality (OCF/NI) 1.49
- Net Margin Trend 12.2% vs 10.9%
Failed (6)
- P/FCF 38.29
- P/B Ratio 3.43
- CapEx intensity
- DCF valuation (Overvalued)
- Earnings Surprise avg 0.2%
- Piotroski F-Score 2/9
Unavailable (8)
- EPS data insufficient
- Dividend Payout NaN%
- Operating Margin NaN%
- Interest Coverage
- Return on Tangible Assets
- Low reliance on intangibles
- Price below Graham Number
- Share Dilution (missing shares data)
Piotroski F-Score
Serious financial concerns
Earnings Quality
High quality: earnings backed by cash
Share Dilution
Buying back shares. Shareholder friendly
Governance
Executive Team
| Name | Title | Age |
|---|---|---|
| Dr. Roland Busch Dipl.Phys. | President, CEO & Chairman of Management Board | 61 |
| Ms. Veronika Bienert | CFO & Member of Management Board | 52 |
| Mr. Cedrik Neike | CEO of Digital Industries & Member of Managing Board | 52 |
| Ms. Judith Wiese | Chief People & Sustainability Officer and Member of Managing Board | 54 |
| Dr. Peter Koerte Ph.D. | CTO, CEO of Siemens Smart Infrastructure, Chief Strategy Officer & Member of Management Board | 50 |
| Dr. Ralf P. Thomas | Special Advisor | 64 |
| Dr. Andreas Christian Hoffmann | General Counsel, Head of the Legal & Compliance Department | 61 |
| Mr. Hanno Kunkel | Chief Compliance Officer and Head of the Global Compliance Organization & Human Rights Officer | 50 |
| Ms. Christiane Ribeiro Guimaraes Hofer | Global Head of Communications | 47 |
| Dr. Jochen Schmitz Ph.D. | Chief Financial Officer of Siemens Healthineers | 59 |
Audit Risk
1
Board Risk
5
Compensation Risk
1
Shareholder Rights Risk
1
Part 2 · The price and when to enter
This part won't tell you whether the company is worth owning: it helps you choose when to buy it, once the fundamentals have convinced you. Inside: technical analysis, potential, historical drawdowns, gamma exposure.
Latest News
Recent headlines for SMAWF, sourced from Markets Gazette.